Recall Record

Fairfield, NJ, United States

Akron Pharma, Inc. recalls

4 recalls recorded since 2018, most recently on 12 December 2024. 2 are listed as ongoing. Status and classification are as published by the FDA.

Recalls4
Ongoing (FDA)2
Terminated or completed2
Class I (FDA)0

Ongoing Class III Drugs

Recall started
12 December 2024
Reason
Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.
Distribution
Nationwide in the US
Initiated
Voluntary: Firm initiated
Recall numbers
D-0195-2025, D-0198-2025, D-0199-2025, D-0194-2025, D-0197-2025, D-0193-2025, D-0196-2025

Ongoing Class II Drugs

Recall started
15 October 2024
Reason
CGMP Deviations
Distribution
Nationwide in the US
Initiated
Voluntary: Firm initiated
Recall number
D-0025-2025

Terminated Class III Drugs

Recall started
17 February 2023
Terminated
9 September 2024
Reason
Labeling: Incorrect or Missing Lot and/or Exp Date
Distribution
Nationwide within the United States
Initiated
Voluntary: Firm initiated
Recall number
D-0454-2023

Terminated Class III Drugs

Recall started
4 August 2022
Terminated
4 December 2023
Reason
Failed Tablet/Capsule Specifications: Imprint "AP 325" is missing from the tablet.
Distribution
Product was distributed to 6 distributors/wholesalers who may have further distributed the product.
Initiated
Voluntary: Firm initiated
Recall numbers
D-1353-2022, D-1352-2022

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.